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A Negative Regulatory Role for Ig-a
during B Cell Development
shown to represent a distinct stage in B cell develop-
ment (Carsetti et al., 1995; Melamed et al., 1998) from
which B cells destined to emigrate to the periphery are
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selected (Allman et al., 1993). Newly formed IgM1 B cellsCH-4005 Basel
must express a functional BCR before leaving the boneSwitzerland
marrow. This requirement has long been evident by the
fact that sIgM-negative pre-B cells are not observed in
the periphery under normal circumstances. This late BSummary
cell developmental checkpoint has also been demon-
strated by a mouse mutant, mb-1Dc/Dc, that expresses aThe development of B cells requires the expression of
signaling impaired BCR. In these mutants, the maturean antigen receptor at distinct points during matura-
peripheral B cell pool is significantly reduced in celltion. The Ig-a/b heterodimer signals for these recep-
number (Torres et al., 1996).tors, and mice harboring a truncation of the Ig-a intra-
The Ig-a/b heterodimer is an integral component ofcellular domain (mb-1Dc/Dc) have severely reduced
the BCR and is required for both surface expressionperipheral B cell numbers. Here we report that imma-
and signaling (Reth, 1992; Cambier et al., 1993; Williamsture mb-1Dc/Dc B cells are activated despite lacking a
et al., 1994; DeFranco, 1997). Whether Ig-a and Ig-bcritical Ig-a-positive signaling motif. As a conse-
make qualitatively different contributions to BCR signal-quence of abnormal activation, transitional immature
ing or are functionally redundant is not yet clear, asIgMhighIgDlow B cells are largely absent in mb-1Dc/Dc mu-
evidence exists to support both views. Distinct cytosolictants, accounting for the paucity of mature B cells.
signaling molecules have been found that differentiallyThus, Ig-a cytoplasmic tail truncation yields an antigen
associate with either Ig-a or Ig-b (Clark et al., 1992),receptor complex on immature B cells that signals
and, consistent with this, studies with cell lines haveconstitutively. These data illustrate a role for Ig-a in
attributed distinct biochemical events with these mole-negatively regulating antigen receptor signaling dur-
cules (Kim et al., 1993; Sanchez et al., 1993; Choqueting B cell development.
et al., 1994; Luisiri et al., 1996; Pao et al., 1998). However,
this conclusion has not been supported by all in vitro
studies (Law et al., 1993; Taddie et al., 1994; WilliamsIntroduction
et al., 1994) nor in vivo, with respect to the ability of
chimeric Ig-a or Ig-b receptors to drive early B cell devel-The expression of distinct B cell antigen receptor (BCR)
opment (Papavasiliou et al., 1995a; Teh and Neuberger,
complexes is strictly monitored at early and late points
1997). In the latter studies, independent chimeric IgM/
during B lymphocyte maturation. These so-called check-
Ig-a and IgM/Ig-b receptors were equally capable of
points for antigen receptor expression ensure that only
promoting B cell development and signaling allelic ex-
useful B cells continue to develop and prevent self-
clusion when expressed as transgenes.
reactive lymphocytes from entering into the mature pe-
Irrespective of potential differences in their signaling
ripheral B cell pool (Rajewsky, 1996). functions, the signaling capacity of both Ig-a and Ig-b
The early and late forms of the antigen receptor com- has been shown to reside with an immunoreceptor
plex have an identical core structure that is composed tyrosine-based activation motif (ITAM) found within the
of an immunoglobulin (Ig) m heavy chain noncovalently cytoplasmic portion of both molecules. Mutation of the
associated with an Ig-a/b heterodimer. The pre-B cell tyrosines in either Ig-a or Ig-b ITAM inhibits early BCR-
receptor (pre-BCR) is the early form of the antigen recep- mediated signal transduction events upon receptor en-
tor complex expressed by B cell progenitors. In the pre- gagement in cell lines (Sanchez et al., 1993; Flaswinkel
BCR, Ig m heavy chain pairs with the surrogate light and Reth, 1994; Taddie et al., 1994; Williams et al., 1994).
chain; the latter structure composed of the l5 and VpreB In accord with these results, mice expressing a chimeric
gene products (Karasuyama et al., 1996). At the subse- IgM/Ig-b transgenic receptor exhibit normal B cell matu-
quent precursor-B (pre-B) cell developmental stage, an ration and allelic exclusion but not when the IgM/Ig-b
IgM is produced by the replacement of surrogate light chimeric receptor harbors mutated ITAM tyrosines (Pa-
chain with k or l conventional Ig light chain. The resulting pavasiliou et al., 1995a, 1995b; Teh and Neuberger,
IgM is deposited on the cell surface with the Ig-a/b 1997). Thus, as suggested from cell line studies, an intact
heterodimer as a BCR complex. By definition the expres- Ig-b ITAM is apparently also required for appropriate
sion of surface IgM (sIgM) by these cells identifies them BCR signaling function during development.
now as immature B cells. However, IgM is expressed at The biochemical and molecular events that follow sIg
variable levels on immature B cells, and those cells that engagement on a B cell has been the subject of intense
express the highest levels of IgM also coexpress low- investigation. Clearly the type of antigen, mode of activa-
to-intermediate levels of IgD. IgMhighIgDlow immature B tion, developmental stage, as well as the environment
cells are transitional immature B cells and have been in which the B cell is activated can influence the resulting
signal transduction cascade (DeFranco, 1997). Despite
the numerous signaling pathways that may result from
sIg engagement, the activation of protein tyrosine ki-* To whom correspondence should be addressed (e-mail: torres@
bii.ch). nases and subsequent phosphorylation of the Ig-a/b
Immunity
528
ITAMs is believed to be an obligate feature in the initia-
tion of virtually all BCR signal transduction scenarios
(Weiss and Littman, 1994; DeFranco, 1997; Clements
and Koretzky, 1999; Kurosaki, 1999). Tyrosine phos-
phorylation of Ig-a and Ig-b, presumably by Src family
tyrosine kinases, allows SH2-containing proteins includ-
ing the Syk tyrosine kinase, to bind to phosphorylated
ITAMs and is an early step in delivering sIg signals to
the nucleus.
To investigate the requirements of antigen receptor
signaling in B cell development, we have previously gen-
erated a mouse mutant, mb-1Dc/Dc, that encodes a trun-
cated Ig-a cytoplasmic domain and that prevents the
expression of the ITAM. Consistent with previous stud-
ies demonstrating the importance of the Ig-a/b ITAMs
in antigen receptor signaling and development, these
animals produce very few mature B cells (Torres et al.,
1996). The B cell deficiency in these animals has been
shown to be the cumulative result of inefficient progres-
sion by B cell precursors through at least two points in
bone marrow B cell development, both of which coincide
with antigen receptor checkpoints. In the present study
we have examined the basis underlying the inefficient
production of mb-1Dc/Dc peripheral B cells in vivo and in
vitro using a recently established reaggregation organ
culture system. The results from these experiments
demonstrate that mb-1Dc/Dc immature B cells are unex-
pectedly activated and, as a consequence, are arrested
in development at the point at which IgD expression
commences in normal development. Thus, in the ab-
sence of the Ig-a cytoplasmic domain, immature B cells
are activated and B cell development is arrested through
a process that appears analogous to that imposed on
B cells expressing a self-reactive receptor.
Results
B Cell Development with a Truncated Ig-a Results
in Fewer Immature B Cells that Are Inefficiently
Exported to the Periphery
mb-1Dc/Dc B lineage cells harbor a truncated Ig-a mole-
cule due to the insertion of a stop codon at residue
181 and only express the first 20 of the 61±amino acid
cytoplasmic tail. Importantly, neither of the tyrosines
within the Ig-a ITAM is present in mb-1Dc/Dc B lineage
cells. Considering the relatively few B lineage cells that
exist in mb-1Dc/Dc animals (see below), direct demonstra-
tion of the truncated Ig-a was facilitated by the introduc-
tion of a bcl-2 transgene into an mb-1Dc/Dc background. Figure 1. B Cell Development in the Presence of the mb-1Dc Muta-
tion Results in a Severely Reduced Peripheral B Cell PoolThus, without overtly protecting any particular develop-
mental stage, mb-1Dc/Dc; bcl-2 mice have an increase in (A) Immunoprecipitation of Ig-b from surface-biotinylated mb-1Dc/Dc;
bcl-2 transgenic total bone marrow reveals a molecular weight ofthe overall number of bone marrow IgM1 cells (data not
approximately 20 kDa for Ig-a due to the mb-1Dc mutation.shown). Figure 1A shows that anti-Ig-b immunoprecipi-
(B) Flow cytometric analysis of wild-type and mb-1Dc/Dc bone marrowtation of wild-type bone marrow cells reveals an approxi-
for the developmentally restricted antigens c-kit, CD25, and IgM.
mate 34 kDa Ig-a polypeptide and two species of ap- Percentages are of total bone marrow cells taken from both femurs
proximately 36 and 39 kDa for Ig-b, as detected after (n 5 5; B6 5 4.1 3 107 6 3.1 3 103; mb-1Dc/Dc 5 4.0 3 107 6 4.0 3 103).
reprobing the membranes with respective anti-Ig-a and (C) Expression of B220 and IgM on B6 and mb-1Dc/Dc splenocytes.
anti-Ig-b antibodies (data not shown). In contrast, the Mutant IgM1 B cells are reduced in cell number .100-fold (5.1 3
105 versus 5.2 3 107, respectively) relative to wild type, althoughIg-a immunoprecipitated with anti-Ig-b from mb-1Dc/Dc;
they display similar proportions of pB130±140 antigen (15% versusbcl-2 transgenic bone marrow has a molecular weight
19%, respectively; bottom histogram).of approximately 20 kDa (Figure 1A) and is consistent
with the predicted truncation. Interestingly, the Ig-b ex-
pressed by mb-1Dc/Dc bone marrow cells is found pre-
dominantly as a 34 kDa species and is similar to an
Ig-a Negatively Regulates BCR Developmental Signals
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Ig-b isoform previously found in primary splenic B cells B2201CD21IgM2 pre-B and IgM1 immature B cells com-
(Friedrich et al., 1993). This 34 kDa Ig-b represents an pared to controls after 6 days of culture.
alternatively glycosylated form of Ig-b that was selec- When B cell maturation was directly compared in par-
tively recovered from low-density splenic B cells, and allel cultures that were seeded with either mutant or
it was suggested that it may preferentially be associated wild-type pro-B cells, it was apparent that mb-1Dc/Dc im-
with the BCR from activated cells (Cambier et al., 1993). mature B cells expressed reproducibly lower levels of
Flow cytometric analysis of wild-type and mb-1Dc/Dc sIgM relative to wild type (Figure 2A). Whereas wild-
bone marrow and spleen is shown in Figures 1B and type cultures contained an immature B cell population
1C. As previously reported (Torres et al., 1996), this rep- composed of IgMlow and IgMhigh cells, mb-1Dc/Dc immature
resentative analysis demonstrates that mb-1Dc/Dc mu- B cells were predominantly IgMlow. Gating on the top
tants display inefficient bone marrow B lymphopoiesis. one-third of wild-type immature B cells that expressed
In particular, the transition of mutant B2201c-kit1 pro- the highest levels of sIgM results in a 5-fold reduction
genitor B cells to B2201CD251 pre-B cells is impaired in the proportion of mutant immature B cells that express
and results in a 3- to 6-fold reduction in the number of similar IgM levels (Figure 2A). The reduction in sIgM
pre-B and IgM1 immature B cells. Furthermore, although expression by mb-1Dc/Dc immature B cells was not an
up to 6-fold fewer in number, these newly generated artifact of maturation in RFLOCs. The same observation
IgM1 immature B cells migrate with significantly reduced was made when pro-B cells were cultured on a stromal
efficiency to the periphery, ultimately resulting in .100- cell line in the presence of IL-7 and were induced to
fold reduction in the absolute number of mature periph- differentiate to immature B cells upon growth factor
eral B cells. Inefficient export of newly formed bone withdrawal (data not shown).
marrow immature B cells was initially indicated by the The expression of IgM on mb-1Dc/Dc bone marrow im-
analysis of BrdU incorporation of splenic B cells follow- mature B cells ex vivo does not necessarily reflect the
ing a short period of in vivo labeling (Torres et al., 1996). reduced levels of IgM found on the analogous popula-
Additional evidence for decreased export of immature tion generated in vitro (compare Figures 2A and 1B).
B cells from the bone marrow is provided by the expres- However, wild-type immature B cells that express the
sion of the pB130±140 antigen expression on splenic B highest levels of IgM also coexpress low-to-intermedi-
cells as recognized by monoclonal antibody (mAb) 493.
ate levels of IgD (Figure 2B). IgMhighIgDlow immature B
This mAb marks immature B cells in the spleen that
cells have been characterized as a distinct immature B
have recently emigrated from the bone marrow (Rolink et
cell stage in bone marrow B cell development (Melamed
al., 1998). mb-1Dc/Dc and wild-type mice display a similar
et al., 1998) referred to as transitional B cells (Carsettifrequency of pB130±1401IgM1 cells in the spleen (15%
et al., 1995). Consistent with the reduced expressionversus 19%, respectively), demonstrating that the num-
levels of sIgM by mb-1Dc/Dc immature B cells generatedber of mb-1Dc/Dc bone marrow immigrants is .100-fold
in vitro, only z7% of these mutant IgM immature B cellsdecreased relative to wild-type (7.7 3 104 versus 9.9 3
coexpress IgD compared with 25%±35% of wild-type106, respectively; Figure 1C).
immature B cells (Figure 2B). Furthermore, this differ-The impaired production of pre-B and mature B cells
ence is also observed in vivo. IgD expression by mb-in mutants coincides with those B cell developmental
1Dc/Dc immature bone marrow B cells ex vivo is also dimin-transitions that are dependent on the expression of a
ished relative to wild type and similar to that found insignaling-competent antigen receptor. Specifically, the
vitro (Figure 2B). These data demonstrate that the pro-pre-BCR is necessary for generating pre-B cells and a
portion of IgMhighIgDlow transitional immature B cells pop-mature BCR is required for migration to the periphery.
ulation is significantly reduced in mutant animals.We have suggested that the deficiency in mb-1Dc/Dc B
Reduced surface IgM expression by mb-1Dc/Dc imma-cell development is a consequence of an impaired ability
ture B cells results from the truncation of the Ig-a cyto-to appropriately signal at the known checkpoints for
plasmic tail. Since Ig-a is important not only for BCRantigen receptor expression (Torres et al., 1996).
signaling but also for surface Ig expression, the reduc-
tion in IgM expression could conceivably result fromNewly Formed mb-1Dc/Dc B Cells Do Not Mature
either aberrant BCR signaling or an impairment in theto the Transitional Immature B Cell Stage
assembly and/or transport of a BCR complex to the cellTo examine the basis for the mb-1Dc/Dc B cell develop-
surface. We have previously established that, althoughmental defects in closer detail, we have employed a
reduced in number, splenic mb-1Dc/Dc B cells expressrecently established reaggregation fetal liver organ
equivalent levels of IgM compared to wild-type B cellsculture (RFLOC) system. This in vitro cell culture sys-
(Torres et al., 1996). Figure 2C confirms this observationtem promotes the maturation of exogenously isolated
and extends it to IgD expression on peripheral mb-1Dc/DcB2201c-kit1 pro-B cells, when seeded into a fetal stro-
and wild-type B cells that carry a functionally rearrangedmal microenvironment, to the IgMhighIgDlow transitional
IgH chain at the IgH locus (Pelanda et al., 1997). Thus,immature B cell stage of development (Figures 2A and
mutant B cells are capable of expressing surface IgM2B). Importantly, the mb-1Dc/Dc developmental blocks ob-
and IgD at levels equivalent to wild type.served in vivo are recapitulated upon reaggregation of
Together these data show that in vitro and in vivo mb-mb-1Dc/Dc pro-B cells with fetal liver stroma (Figure 2A,
1Dc/Dc B cell development is characterized by a significantright panels). Similar to what is observed in vivo, RFLOC
diminution of the IgMhighIgDlow transitional immature Bmb-1Dc/Dc B cell development results in an increased
cell population, and this most likely reflects improperproportion of B2201c-kit1 pro-B cells and a concomi-
tant 3- to 6-fold reduction in absolute numbers of signaling by the mutant BCR.
Immunity
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Figure 2. B Cell Development in Fetal Liver Organ Cultures Reveals mb-1Dc/Dc Pro-B Cells Do Not Mature to the IgMhighIgDlow Transitional
Immature B Cell Stage
(A) In vitro B cell development of sorted B2201c-kit1 bone marrow wild-type (left panels) and mb-1Dc/Dc (right panels) pro-B cells reaggregated
in fetal liver organ cultures. After 6 days of culture, cells were analyzed by flow cytometry for surface expression of the developmentally
associated surface antigens B220, c-kit, CD2, and IgM.
(B) IgM and IgD expression on wild-type (left) and mb-1Dc/Dc (right) immature B cells from RFLOC (top) or bone marrow (bottom) reveals an
absence of the IgMhighIgDlow transitional immature B cell population in mutant animals.
(C) Coexpression of IgM and IgD on splenocytes from wild-type (left) and mb-1Dc/Dc (right) animals that carry a targeted VDJ transgene.
Histograms of CD191 splenocytes reveal comparable sIgM (left) and increased sIgD (right) levels on mutant (gray dotted lines) cells relative
to wild type (solid black lines).
Development of Immature B Cells In Vitro in the IgM1 immature B cells was not augmented with respect
to either cell number or level of surface IgM expressionPresence of a Constitutive BCR Signal
In an attempt to compensate for the presumed defective (Figure 3). On the contrary, RFLOC B cell development
in the presence of anti-Ig-b exaggerated the mb-1Dc/DcBCR signaling in mb-1Dc/Dc B cell development, RFLOC
B cell maturation was followed in the presence of a developmental phenotype, resulting in a 2- to 4-fold
reduction in the number and proportion of mb-1Dc/Dc IgM1constitutive BCR-mediated signal. To achieve this we
used a recently described mAb that recognizes an extra- B cells. Furthermore, the immature B cells that did de-
velop expressed diminished levels of sIgM relative tocellular epitope of Ig-b (Koyama et al., 1997). This mAb,
when injected into RAG2/2 mice, is capable of relieving control treated cultures (Figure 3E versus 3F).
The same was true for wild-type RFLOCs: in the pres-the pro-B to pre-B cell developmental arrest that exists
in those animals (Nagata et al., 1997). ence of anti-Ig-b, fewer immature B cells were gener-
ated, which expressed reduced levels of surface IgMAnti-Ig-b or control (145±2C11) mAb was added from
the onset of wild-type and mb-1Dc/Dc organ cultures and (Figures 3A and 3B). The reduction in sIgM levels in anti-
Ig-b-treated wild-type cultures was also accompaniedB cell development assessed 7 days later. Addition of
the anti-Ig-b mAb resulted in an increase in the number by a .3-fold decrease in the proportion of IgM1IgD1
immature B cells (Figures 3C and 3D). Interestingly, theof c-kit1 pro-B cells generated in both wild-type and
mutant organ cultures (data not shown). Despite increas- presence of continual BCR stimulation in wild-type or-
gan cultures generated IgM1 immature B cells that wereing pro-B cell numbers, the maturation of mb-1Dc/Dc
Ig-a Negatively Regulates BCR Developmental Signals
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for intracellular phosphotyrosine, and subsequently
stained for surface IgM and B220 followed by flow cyto-
metric analysis. As shown in Figure 4A, this analysis
revealed that mb-1Dc/Dc immature B cells indeed had in-
creased intracellular phosphotyrosine levels relative to
control B220lowIgM1 immature B cells. The heightened
intracellular phosphotyrosine level relative to control
was reproducible (n 5 4) and appeared specific for mb-
1Dc/Dc immature IgM1 B cells, since the overall levels of
intracellular phosphotyrosine in the B220lowIgM2 popula-
tion was decreased in mutants compared to controls.
To confirm that mb-1Dc/Dc bone marrow immature B
cells had in vivo elevated levels of tyrosine phosphoryla-
tion, immature cells from mutant and control strains
were enriched by cell sorting and subjected to Western
analysis (Figure 4B). To avoid BCR engagement in the
purification of this population, cells were sorted as a
B220lowc-kit2 population and further gated to include
only those cells with small forward size scatter. The
resulting population of cells from this isolation protocol
is devoid of B220high mature B cells but contains a
large proportion of sIgM2 pre-B cells. However, given
that the ratio of pre-B to immature B cells is approxi-
mately the same in control and mutant animals, the
inclusion of these cells would be expected to influence
the analysis of both strains similarly. Consistent with
the flow cytometric analysis, Figure 4B directly demon-
strates that mb-1Dc/Dc immature B cells display increased
levels of tyrosine phosphorylated substrates compared
to wild-type immature B cells. These analyses also re-
vealed distinct phosphorylated substrates between mu-
tant and wild-type cells (e.g., z70 kDa protein in Figure
4B); however, the appearance of these differentially
Figure 3. In Vitro B Cell Development in the Presence of Continual phosphorylated substrates varied in different experi-
BCR Stimulation Yields Newly Formed Wild-Type and mb-1Dc/Dc Im- ments. We conclude that the Ig-a truncation results in
mature B Cells Expressing Diminished Levels of sIgM and sIgD a quantitative increase in tyrosine phosphorylation.
RFLOC maturation of wild-type (A±D) and mutant (E±H) B2201c-kit1 Under normal circumstances the sIg expressed on B
pro-B cells in the presence of control (A, C, E, and G) or anti-Ig-b
lymphocytes is continually internalized and replaced at(B, D, F, and H) mAb. After 7 days of in vitro culture, cells were
the surface with newly synthesized Ig. An inability toharvested, stained for the indicated antigens, and analyzed by flow
internalize sIgM could be envisioned to lead to sustainedcytometry.
BCR expression, signaling, and, consequently, activa-
tion. However, this was considered unlikely, as a defi-
ciency in sIg internalization would be predicted to yieldremarkably similar to those found in untreated mb-1Dc/Dc
B cells with increased sIgM levels. Nevertheless, thisorgan cultures (compare Figure 3B to Figure 3E and
possibility was directly examined, and mutant immatureFigure 3D to Figure 3G). The similarities between mb-
bone marrow B cells were found to downregulate IgM1Dc/Dc and BCR-augmented wild-type B cell maturation
with similar kinetics and to similar levels compared toinclude diminished numbers of immature B cells, de-
the same wild-type populations in response to IgM en-creased levels of surface IgM expression, and a reduced
gagement (Figure 4C).proportion of cells that coexpress IgD. These data sug-
These data together demonstrate that truncation ofgested to us that the phenotype of mb-1Dc/Dc immature
the Ig-a cytoplasmic tail, including the ITAM, results inB cells, as well as the diminution in the numbers and
activated immature B cells and that this heightenedproportions of this population, might be the result of
state of activation does not arise from sustained BCRhyperactive rather than insufficient BCR signaling during
expression. These data further suggest that Ig-a and,development.
specifically, its cytoplasmic tail, have a role in repressing
the BCR signaling at the IgM1 immature B cell stage ofmb-1Dc/Dc Newly Generated Bone Marrow B Cells
development.Have Increased Levels of Tyrosine-
Phosphorylated Proteins
We next directly examined whether mb-1Dc/Dc immature mb-1Dc/Dc Immature B Cells Express the B7-2
Activation AntigenB cells were activated in vivo as might be expected
in the presence of constitutive BCR signaling. In initial We have previously reported that peripheral mb-1Dc/Dc B
cells display a resting mature phenotype that includesexperiments, wild-type and mutant bone marrow cells
were fixed in paraformaldehyde, permeabilized, stained essentially no expression of the CD86 antigen (Figure
Immunity
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Figure 4. mb-1Dc/Dc IgM1 Immature B Cells
Are Activated In Vivo as Demonstrated by Ele-
vated Intracellular Phosphotyrosine Levels
(A) Flow cytometric analysis of intracellular
phosphotyrosine levels in wild-type and mb-
1Dc/Dc B220lowIgM1 immature B cells. BL6 and
mb-1Dc/Dc total bone marrow cells were fixed,
permeabilized, stained intracellularly with a
mAb recognizing phosphotyrosine, and sub-
sequently stained for surface B220 and IgM.
Cells were gated either on B220lowIgM2 cells
(left histograms) or B220lowIgM1 cells (right
histograms). The latter gate is conservative
to ensure the exclusion of mature B cells.
Wild-type and mb-1Dc/Dc cells are represented
by black solid and gray dotted lines, respec-
tively.
(B) Small, B220lowc-kit2 bone marrow cells
were sorted from control and mutant mice
and equivalent protein from whole cell lysates
run on an 8% acrylamide gel. After transfer,
membranes were probed with an anti-phos-
photyrosine antibody and revealed by chemi-
luminscence.
(C) Wild-type (solid line) and mb-1Dc/Dc (dashed
line) immature B cells downmodulate IgM to
comparable levels and with similar kinetics.
5A; Torres et al., 1996). However, having shown that vated in vivo and that BCR stimulation of wild-type im-
mature B cells recapitulates the mb-1Dc/Dc phenotype.bone marrow mb-1Dc/Dc immature B cells are activated
in vivo, we sought to determine whether any activation
antigens may be present on mb-1Dc/Dc newly generated Discussion
IgM1 B cells. C57BL/6 and mb-1Dc/Dc bone marrow cells
were isolated and the expression of a number of mature To investigate how Ig-a contributes to antigen receptor
signaling in vivo, we have previously generated a mouseB cell activation antigens was examined. While essen-
tially little or no difference was observed in the expres- mutant, mb-1Dc/Dc, that lacks the carboxy-terminal two-
thirds of the Ig-a cytoplasmic tail (Torres et al., 1996).sion of CD69, class II, and CD80 between mutant or
control immature B cells, there was a clear upregulation Consistent with the large body of evidence establishing
ITAMs as mandatory for antigen receptor signaling, Bin the expression of the CD86 antigen on all B220lowIgMlow
B cells in mb-1Dc/Dc bone marrow (Figure 5B; data not lymphopoiesis in these mutants is severely compro-
mised. Considering the lack of the Ig-a ITAM, we initiallyshown). In contrast, the equivalent IgMlow immature B cell
population from C57BL/6 bone marrow did not express attributed the impaired maturation to inefficient antigen
receptor signaling at both early and late developmentalappreciable levels of CD86 unless stimulated via the BCR
overnight (Figure 5C). CD86 is a well-characterized activa- transitions. The latter transition involves the migration
of newly formed immature B cells to the periphery andtion antigen whose expression is upregulated on mature
B cells upon BCR engagement (Hathcock et al., 1994; their recruitment into the mature B cell pool. Although
mb-1Dc/Dc bone marrow harbors up to 6-fold fewer imma-Lenschow et al., 1994). These data provide additional
evidence that mb-1Dc/Dc immature IgM1 B cells are acti- ture B cells compared to controls, the peripheral B cell
Ig-a Negatively Regulates BCR Developmental Signals
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IgMhighIgDlow transitional immature B cell stage is recapit-
ulated in a recently established in vitro organ culture
system. In contrast to the ex vivo analysis of bone mar-
row, where B cell development is examined at steady
state equilibrium, this in vitro system allows the direct
comparison of B cell progenitors to mature as a cohort
to late stage immature B cells. Direct comparison of
wild-type and mb-1Dc/Dc B lymphopoiesis in RFLOCs re-
vealed that mutant cultures were deficient in the popula-
tion of IgMhighIgDlow transitional B cells. It is precisely this
bone marrow population that emigrates to the periphery,
where they are recruited into the mature long-lived pe-
ripheral population (Allman et al., 1993). The near ab-
sence of IgMhighIgDlow transitional B cells would severely
diminish the export of immature B cells and would ac-
count for the paucity of peripheral B cells found in mb-
1Dc/Dc animals.
Although the percentage of IgMhighIgDlow transitional
immature B cells is reduced in mb-1Dc/Dc bone marrow,
interestingly, the levels of sIgM expression on bone mar-
row immature B cells is not diminished to the same
extent as when generated in vitro. While the basis for
this apparent discrepancy is not fully understood, we
support the idea that a cell type(s) (Sandel and Monroe,
1999) or factor(s) found in the bone marrow microenvi-
ronment preferentially permits the development of
IgMhigh expressing mb-1Dc/Dc immature B cells relative to
the fetal microenvironment used in RFLOCs. Consistent
with this hypothesis, we do not find IgMhigh immature B
cells in mb-1Dc/Dc newborn fetal liver, although IgMhigh
cells are present in newborn spleen, when compared to
analogous wild-type populations (data not shown).
Several lines of evidence independently support the
view that deregulated BCR signaling and not an inability
to express appropriate levels of sIg accounts for the lack
of mb-1Dc/Dc transitional immature B cells. First, mutant B
lineage cells do not have an inherent problem in express-
ing high levels of sIg. Comparable levels of sIgM and
sIgD are observed on splenic mb-1Dc/Dc and wild-type B
cells (Figure 2D; Torres et al., 1996). Second, providing
Figure 5. CD86 Expression by mb-1Dc/Dc IgM1 Immature but Not Ma- a surrogate BCR signal by anti-Ig-b treatment during
ture B Cells and Induction on Wild-Type Immature B Cells mb-1Dc/Dc B cell development exaggerated the pheno-
Expression of CD86 was examined on splenic IgM1 B cells (A) or type, i.e., fewer immature B cells were produced that
bone marrow B220lowIgMlow immature B cells (B) from C57BL/6 (solid expressed lower levels of sIgM. Similarly, anti-Ig-b treat-
black lines) and mb-1Dc/Dc (shaded gray) animals. Histogram insets ment of wild-type cultures results in immature B cells
represent the same data but normalized for cell numbers. (C) Purified
that are IgMlowIgD2, resembling those found in untreatedC57BL/6 B220lowIgM1 immature B cells were sorted and placed in
mb-1Dc/Dc organ cultures (Figure 3). These data demon-culture overnight with either medium (solid line), 0.05 mg/ml (thin
strate that a signal(s) transmitted by the BCR on newlyline), or 0.5 mg/ml (shaded gray) of anti-IgM followed by examination
of CD86 expression. formed IgM1 immature B cells arrests development at
the IgMlow B cell stage. This is also consistent with the
similar developmental arrest observed in mice that over-
pool is diminished .100-fold in cell number. This reduc- express an active form of the Btk tyrosine kinase (Maas
tion can be partly explained by an altered lifespan of et al., 1999), which is known to be activated upon BCR
peripheral B cells as they do not accumulate with age engagement (Aoki et al., 1994; Saouaf et al., 1994). Last,
(data not shown). However, bone marrow export of mb- in two well-characterized Ig transgenic tolerance mod-
1Dc/Dc immature B cells is also decreased relative to pro- els, bone marrow B cell development in the presence
duction as indicated by short-term BrdU-labeling exper- of a membrane-bound self-antigen results in the elimina-
iments (Torres et al., 1996) and proportion of splenic tion of IgMhigh immature B cells (and mature B cells) but
pB130±1401 (Figure 1C) (Rolink et al., 1998). The experi- spares the IgMlow immature cells (Nemazee and Burki,
ments presented here identify the basis for this ineffi- 1989; Hartley et al., 1991). Considering that mb-1Dc/Dc
cient export and indicate that Ig-a has an additional role IgM1 bone marrow B cells are indeed activated (see
in B cell development besides positive signaling via its below), these data provide strong evidence that the de-
ITAM. creased number of IgM1 immature B cells, and the vir-
tual absence of mb-1Dc/Dc IgMhighIgDlow transitional B cells,The development of committed pro-B cells to the
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is a consequence of deregulated BCR signaling due to IgM1 immature B cells. The inability of mb-1Dc/Dc imma-
ture B cells to recruit this putative negative regulatorthe Ig-a truncation.
The phosphorylation of the Ig-a/b ITAMs is one of results in constitutive BCR signaling upon sIgM expres-
sion. Although a number of candidates exist that couldthe earliest membrane-proximal events in BCR signaling
and is believed to be an essential feature in the propaga- potentially negatively regulate BCR activity during B cell
development, the SHP-1 protein tyrosine phosphatasetion of all signal transduction cascades that result from
antigen receptor engagement (Weiss and Littman, 1994; has previously been shown to fulfill this role in vivo
(Cyster and Goodnow, 1995) and physically associatesDeFranco, 1997; Reth and Wienands, 1997; Clements
and Koretzky, 1999; Kurosaki, 1999). The profound im- with Ig-a in resting splenic B cells (Pani et al., 1995).
While these data are consistent with a model in whichpairment in mb-1Dc/Dc B lymphopoiesis was consistent
with this notion. However, in the absence of rigorous the activation of mb-1Dc/Dc immature B cells results from
an inability of SHP-1 to be recruited to the BCR, thisbiochemical analyses, owing to the paucity of B lineage
cells found in the mb-1Dc/Dc mutants, this interpretation remains speculative and requires further investigation.
Nevertheless, it is clear that the cytoplasmic truncationwas based on the assumption that the absence of the
Ig-a ITAM would lead to ªinferiorº antigen receptor sig- of Ig-a results in activated IgM1 immature B cells and
implies that Ig-a has a role in repressing constitutivenaling compared to the wild type. It was therefore unex-
pected to find that IgM1 immature B cells with a trunca- signaling by the antigen receptor on immature B cells.
The development of B lymphocytes in mb-1Dc/Dc mu-tion of the carboxy-terminal two-thirds of the Ig-a
cytoplasmic domain, including the ITAM, have increased tants demonstrates that IgMlow immature B cells can
mature in the presence of a constitutive BCR signal. Inlevels of intracellular tyrosine phosphorylation and aber-
rantly express the CD86 activation antigen. That is, mb- contrast, the maturation of these IgMlow immature B cells
to late/transitional IgMhighIgDlow immature B cells is incom-1Dc/Dc IgM1 immature B cells display an activated pheno-
type similar to that resulting from BCR engagement on patible with an increased level of constitutive antigen
receptor signaling. Thus, B lymphopoiesis in mb-1Dc/Dcwild-type B cells.
We considered that the activation of mutant immature mutants is in accord with previous findings gathered
from the analysis of B cell development in transgenicB cells could potentially result from sustained sIgM ex-
pression as a consequence of the Ig-a truncation. In mouse models of B cell tolerance (Nemazee and Burki,
1989; Hartley et al., 1991). In addition, those previousparticular, it has previously been shown that constitutive
internalization of sIg expressed by a myeloma cell line observations are extended by these data to include im-
mature B cells that express a more physiological VHwas dependent on the Ig-a cytoplasmic domain (Cas-
sard et al., 1998). However, mb-1Dc/Dc immature B cells repertoire as opposed to the development of a mono-
clonal population in transgenic animals. Moreover, thewere found to be competent in downmodulating sIgM
in a manner comparable to wild type in response to data presented here provide in vivo evidence that IgMlow
and IgMhigh immature B cells, as functionally distinctsIg engagement. Thus, sustained BCR expression by
mutant immature B cells does not appear to account bone marrow developmental populations, respond dif-
ferentially to an apparently similar BCR signal (Melamedfor the activation of mb-1Dc/Dc immature B cells. Whether
the discrepancy between the results presented here and et al., 1998).
In summary, we demonstrate that mb-1Dc/Dc IgM1 im-those previously reported reflects the difference be-
tween primary and cultured cells or between immature mature B cells are activated and do not efficiently mature
to the IgMhighIgDlow late transitional immature B cell stage.B cells and a terminally differentiated myeloma is not
clear but it deserves further investigation. In summary, As a consequence, newly formed mutant B cells are not
efficiently exported to the periphery and are most likelyour data fully support the notion that mb-1Dc/Dc immature
B cells are activated as a result of constitutive BCR removed from the developmental pathway via a mecha-
nism similar to that employed in the negative selectionsignaling.
Although the Ig-a ITAM has clearly been shown to of autoreactive bone marrow B cells. These findings are
compatible with deregulated constitutive BCR signalingfulfill a positive signaling role upon BCR engagement,
the development of immature B cells in its absence in the absence of the Ig-a cytoplasmic tail and illustrate
an additional role for Ig-a in regulating BCR signalingresults in activation. The mb-1Dc mutation, however,
during development.truncates the last 41 residues of the 61±amino acid cyto-
plasmic tail, and the ITAM, in its minimum configuration,
accounts for only 15 residues of this deleted region. It Experimental Procedures
is feasible that the Ig-a cytoplasmic tail can contribute
Micetoward BCR signaling in a manner independent of the
C57BL/6 mice were purchased from Biological Research Labora-ITAM, a possibility that has not been thoroughly investi-
tories (FuÈ llinsdorf, Switzerland). B6-Ly5a, Em-bcl-2 (Strasser et al.,
gated. Indeed, residues within the Ig-a/b ITAMs and 1991), 383IgHi (Pelanda et al., 1997), and mb-1Dc/Dc (Torres et al.,
independent of the tyrosines have been shown to serve 1996) mice were bred and housed under pathogen-free conditions
as docking sites for cytosolic signaling molecules such in the Basel Institute for Immunology animal facilities. The 383IgH
chain transgene, which is specific for particular MHC class I mole-as protein tyrosine kinases (Clark et al., 1994) that can
cules when expressed with the appropriate IgL chain, was generatedalso influence antigen receptor signaling.
by the insertion of a functionally rearranged VDJ gene segment atThe molecular basis for the activation of mutant IgM1
the IgH chain locus (Pelanda et al., 1997). It is present as a single
immature B cells is not yet clear. However, we propose copy and is expressed in an appropriate developmental manner
that the Ig-a cytoplasmic domain functions to recruit a exerting efficient allelic exclusion. For timed matings, the initial iden-
tification of a vaginal plug was considered day 0.cytosolic molecule that attenuates BCR signaling by
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Reaggregation Fetal Liver Organ Cultures 150 mM NaCl, 1 mM EDTA, 1 mM phenylmethylsufonyl fluoride, 1
mM Na3VO4, 1 mM NaF, and 1 mg/ml of aprotinin, leupeptin, andDay 15 pregnant B6-Ly5a mice were g-irradiated with 950 rad, and
intact fetal livers were carefully removed from embryos, cut into pepstatin) and incubated at 48C for 15 min on an orbital shaker.
Lysates were subsequently centrifuged at 14000 3 g at 48C for 15z1±1.5 mm2 pieces, and placed on 25 mm2 membrane (Corning
Nucleopore Track-Etch Membrane 0.8 mm, catalog number 110609O) min and supernatants assayed for protein content (BioRad). Equiva-
lent amounts of protein were heated at 958C for 5 min and subjectedand floated on IMDM with antibiotics, 2-ME, and 10% FCS. Explants
were incubated at 378C for 6 days during which host hematopoietic to SDS-PAGE on an 8% acrylamide gel.
For immunoprecipitation, total bone marrow cells from B6 andprogenitors were eliminated. Subsequently, fetal liver explants were
transferred to PBS/2% FCS and single-cell suspensions generated. mb-1Dc/Dc animals were isolated and surface biotinylated by incubat-
ing 107 cells with 100 mg/ml of Sulfo-NHS-biotin (Pierce) for 10 minSorted adult (5±8 weeks) bone marrow B2201 (or CD191) c-kit1 B
lineage progenitor cells were sorted and added to the fetal liver at room temperature. After a further 5 min incubation with IMDM,
cells were washed three times with PBS and lysed. Lysates werestroma cell suspension at 4 3 104 progenitor cells per fetal liver
equivalent (FLE). Twenty microliters of this slurry, containing 2 3 precleared by the addition of control antibody and Sepharose-con-
jugated protein G (Pharmacia), followed by incubation at 48C over-104 progenitors and one half of a fetal liver equivalent, was placed
on a 13 mm membrane (Corning 0.8 mm, catalog number 110409) night while rotating. Beads were washed twice with lysis buffer and
incubated with anti-B29 for 4 hr at 48C while rotating. Sepharose-and floated on SF medium (IMDM medium containing penicillin/
streptomycin, MEM nonessential amino acids [GIBCO-BRL], 5 mg/ conjugated protein G was added for the last 2 hr of incubation, after
which beads were washed three times with lysis buffer. Immunopre-ml insulin [Sigma], 50 mM 2-b-mercaptoethanol, and 10% [v/v] Pri-
matone RL [Quest International, Bussum, Netherlands]) supple- cipitated proteins were resuspended in lysis buffer and heated to
958C for 3 min, and samples were subjected to SDS-PAGE on amented with 2% FCS (Boehringer Mannheim) in the presence of
2.0% (z300 ng/ml) IL-7 conditioned medium. Repopulated fetal liver 12% gel.
Proteins were transferred to a Hybond-P PVDF membrane (Amer-organ cultures were incubated at 378C for 6±7 days; cells were
harvested, filtered, and viable cells counted using a hematocyto- sham) using semi-dry transfer and filters incubated with TBS-Tween
(1%) with 5% chicken serum for 1 hr at room temperature or over-meter and Trypan blue.
night at 48C. Filters were incubated with anti-phosphotyrosine
(4G10)-HRP or streptavidin-HRP (Upstate Biotechnology) for 1 hr atAntibodies
Monoclonal antibodies used in this study were those recognizing room temperature and washed four times, and proteins were de-
tected by chemiluminscence according to the manufacturer's proto-the CD45 allotypes Ly5a (A20-1.7) and Ly5b (104-2.1); the pan-B cell
antigens B220 (CD45; RA3-6B2) and CD19 (1D3); developmental col (Pierce).
For intracellular phosphotyrosine staining, bone marrow cellsstage±restricted antigens c-kit (CD117; ACK4), CD25 (IL2ra; 7D4),
IgM (R33-24), and IgD (1-3.5); and the activation antigens CD86 were fixed in 2% paraformaldehyde and washed twice with PBS.
FITC-anti-pTyr (4G10; Upstate) was appropriately diluted in PBS/(B7-2; GL1), CD80 (B7-1; 1G10), CD69 (H1.2F3), and I-A (AF6-120).
Antibodies directly conjugated to phycoerythrin (PE) or allophycocy- 2% FCS/0.5% saponin (Sigma) and cells were stained for 30 min at
room temperature. After washing twice with saponin buffer, cellsanin (APC) (B220, CD25, CD86, and CD80) were purchased from
Pharmingen; all other antibodies were purified in our lab and directly were washed once with PBS/2% FCS and stained for surface IgM
and B220 using standard protocol.Fluos- (Boehringer Mannheim), biotin-, or Cy5-labeled using stan-
dard protocols. Second-step streptavidin-APC was purchased from
Molecular Probes (Leiden, Netherlands). Immature B Cell Stimulation
Purified anti-Ig-b (CD79b; HM79) was purchased from Phar- B220lowIgM1 immature B cells were sorted to .95% purity from total
mingen. HM79 and 145±2C11, as control, were added to RFLOC bone marrow and incubated with different concentrations of goat
cultures at 5 mg/ml throughout the culture period. Rabbit anti-Ig-b anti-mouse IgM (Southern Biotechnology) at 5 3 105 cells/ml. After
and -Ig-a antiserum were a kind gift from David Mason (Oxford, overnight incubation (14 hr), cells were harvested, stained with anti-
United Kingdom). CD86 (B7.2), and examined by flow cytometry.
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